NCT03433274: A trial that was reported late by Abbott Medical Devices
This trial has reported, although it was 174 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03433274 |
|---|---|
| Title | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 15, 2018 |
| Completion date | May 15, 2024 |
| Required reporting date | May 15, 2025, midnight |
| Actual reporting date | Nov. 5, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 174 |